Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Total Liabilities (2016 - 2025)

Conmed (CNMD) has disclosed Total Liabilities for 16 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 3.79% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Dec 2025, down 3.79%, and an annual FY2025 reading of $1.3 billion, down 3.79% over the prior year.
  • Total Liabilities was $1.3 billion for Q4 2025 at Conmed, down from $1.3 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.6 billion in Q3 2022 and bottomed at $980.6 million in Q4 2021.
  • Average Total Liabilities over 5 years is $1.3 billion, with a median of $1.4 billion recorded in 2024.
  • The sharpest move saw Total Liabilities surged 58.28% in 2022, then fell 9.59% in 2024.
  • Year by year, Total Liabilities stood at $980.6 million in 2021, then soared by 58.28% to $1.6 billion in 2022, then dropped by 5.56% to $1.5 billion in 2023, then fell by 8.34% to $1.3 billion in 2024, then fell by 3.79% to $1.3 billion in 2025.
  • Business Quant data shows Total Liabilities for CNMD at $1.3 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.3 billion in Q2 2025.